This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Washington Heights-Inwood Columbia Aging Project | |
|---|---|
| Name | Washington Heights-Inwood Columbia Aging Project |
| Other names | WHICAP |
| Established | 1992 |
| Location | Washington Heights, Manhattan, Inwood, Manhattan, Columbia University |
| Focus | Alzheimer's disease, dementia, cognitive aging, epidemiology |
| Principal investigators | José A. Luchsinger, Jennifer J. Manly |
| Funding | National Institute on Aging, National Institutes of Health |
Washington Heights-Inwood Columbia Aging Project The Washington Heights-Inwood Columbia Aging Project is a longitudinal, community-based cohort study of cognitive aging and dementia conducted in northern Manhattan in collaboration with Columbia University Irving Medical Center and affiliated institutions. The project combines neuropsychological assessment, clinical diagnosis, genetic analysis, and neuroimaging to investigate risk factors for Alzheimer's disease and related dementias among a diverse, predominantly Hispanic and African American urban population. The study has produced influential findings shaping clinical practice, health policy, and translational research across neurology, psychiatry, and public health.
The study focuses on the epidemiology of Alzheimer's disease, vascular dementia, and cognitive decline by integrating longitudinal clinical evaluations, neuropsychological batteries, neuroimaging modalities like magnetic resonance imaging, and biomarker studies including APOE genotyping and cerebrospinal fluid assays. Investigators collaborate with centers such as New York-Presbyterian Hospital, Columbia University Medical Center, and consortiums including the National Institute on Aging Alzheimer's Disease Centers program and multi-site initiatives like the Alzheimer's Disease Neuroimaging Initiative. The cohort has informed diagnostic criteria referenced by organizations such as the American Psychiatric Association and the Alzheimer's Association.
WHICAP was launched in the early 1990s with foundational leadership from clinicians and epidemiologists at Columbia University, building on community partnerships in Washington Heights, Manhattan and Inwood, Manhattan. Initial funding came from the National Institute on Aging and subsequent support has been provided by the National Institutes of Health, private foundations, and institutional resources from Columbia University Irving Medical Center. Over time, supplemental grants have linked the project to federal programs such as the National Alzheimer's Project Act initiatives and collaborative networks including the Hispanic Established Populations for the Epidemiologic Study of the Elderly affiliates and multi-center consortia funded by the National Institute on Aging.
WHICAP employs a longitudinal cohort design with baseline and follow-up assessments occurring at regular intervals. Methods include standardized neuropsychological batteries adapted from instruments used by investigators affiliated with Mount Sinai Health System and New York University Grossman School of Medicine, structured clinical interviews modeled on protocols endorsed by the National Institute on Aging-Alzheimer's Association diagnostic workgroups, and neurologic examinations following criteria used in clinics at Columbia University Irving Medical Center. Imaging protocols align with scanners and sequences standardized across academic centers including Weill Cornell Medicine and SUNY Downstate Health Sciences University. Genetic analyses have utilized genotyping platforms comparable to those used by the International Genomics of Alzheimer's Project.
Participants are community-dwelling older adults recruited from neighborhoods served by Columbia University Irving Medical Center in northern Manhattan, with deliberate oversampling of individuals identifying as Hispanic and Latino Americans and African Americans. Recruitment strategies leveraged partnerships with local organizations such as community health centers, senior centers, and faith-based groups similar to collaborations seen between academic centers and community organizations across New York City. Inclusion criteria emphasize age thresholds consistent with cohorts like the Framingham Heart Study for cardiovascular aging and exclude conditions incompatible with longitudinal follow-up. Retention strategies mirror best practices from cohort studies including the Cardiovascular Health Study.
WHICAP investigators have published widely on incidence and prevalence estimates of Alzheimer's disease and cognitive impairment across racial and ethnic groups, reporting contributions of vascular risk factors such as hypertension, diabetes mellitus, and stroke to cognitive decline—findings cited alongside population studies like the Rotterdam Study and the Baltimore Longitudinal Study of Aging. Work from WHICAP has elucidated interactions between APOE genotype, socioeconomic indicators, and neuroimaging markers including white matter hyperintensities and hippocampal atrophy; these results have been referenced in meta-analyses coordinated by groups including the Global Alzheimer's Association Interactive Network. Key publications appear in journals such as Neurology (journal), JAMA Neurology, Annals of Neurology, and Alzheimer's & Dementia.
Findings from the project have influenced clinical risk assessment frameworks used by neurologists at academic centers including Columbia University Irving Medical Center and community clinics, informed public health strategies addressing cardiovascular risk control in aging populations as advocated by the Centers for Disease Control and Prevention, and contributed to genetic counseling approaches adopted by clinics aligned with the National Society of Genetic Counselors. The cohort's data have been incorporated into multi-cohort meta-analyses and translational initiatives involving pharmaceutical and biomarker consortia such as industry collaborations with the Alzheimer's Disease Neuroimaging Initiative and academic partnerships with the Mount Sinai Alzheimer's Disease Research Center.
Ethical oversight for WHICAP follows institutional review board protocols at Columbia University, with informed consent procedures attentive to linguistic and cultural needs characteristic of populations in Washington Heights, Manhattan and Inwood, Manhattan. Data sharing policies balance participant privacy requirements under regulations like the Health Insurance Portability and Accountability Act with scientific transparency, contributing de-identified datasets to controlled-access repositories and collaborative consortia similar to governance models used by the National Institute on Aging data-sharing initiatives. Community-engaged governance and return-of-results practices reflect standards developed in other cohort studies such as the All of Us Research Program.
Category:Epidemiological studies Category:Alzheimer's disease research